MedTrace Logo

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

NCT02339987 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2019-02-21

No results posted yet for this study

Summary

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)

Conditions

Sponsors & Collaborators

  • Saint John's Cancer Institute

    lead OTHER

Principal Investigators

  • Santosh Kesari, MD, PhD · Saint John's Cancer Institute

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-06-04
Completion
2018-06-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02339987 on ClinicalTrials.gov